Archive | Pharmacy Benefit Reviews

New Approaches to Managing High-Cost Drugs

Prescription drugs are critical to any effective healthcare system, but in the U.S. they are also a growing financial burden on patients, employers and care providers, many of whom struggle to keep up with their high costs. According to separate reports from the Medicare Payment Advisory Commission and the IMS Institute for Healthcare Informatics, prescriptions accounted for a […]

An Update on the Opioid Crisis

The opioid crisis continues to loom in healthcare, as more individuals become addicted to and die from lawful and illegal forms of opioids. While controlled substances such as heroin are to blame for much of the problem, prescription medications are also a contributor. Variation in how physicians treat chronic pain and non-nerve-related back pain and […]

Quick Reference Guide to Drug Utilization Reviews [Infographic]

The 21st Century Cures Act, the opioid crisis, and the cost of pharmaceuticals dominated the headlines of 2016, highlighting the importance of understanding how prescription drugs work in today’s healthcare industry. One valuable tool used by employers, health plans and pharmacists is Drug Utilization Review (DUR). AMR created a quick reference guide to DUR so you […]

Changes in the Exceptions Process in Prescription Coverage [Infographic]

Prescription drug coverage is changing in 2017, with new specific rules for the exceptions process. Take a look at our latest infographic to find out how the exceptions process may affect your prescription!  

Biosimilar Drugs – An Infographic

AMR’s latest infographic looks at the both the benefits and concerns of Biosimilar drugs.

FDA’s Drug Approval Process – How it Fits into the US Health Delivery System

The U.S. Food and Drug Administration has a rigorous drug approval method, but recent years have shown that even this thorough process undergoes certain trends. Each year more new drug applications (NDA) are submitted and approved, including specialty drugs. The annual increase in the approval rates of novel and specialty drugs may signal a general […]

PBMs: Past, Present and Future

Not every aspect of the shifting health care market is clear, but one thing is for certain: The importance of pharmacy benefit management companies (PBMs) is increasing. Drug prices are rising, and PBMs continue to act as intermediaries between insurance companies, pharmacies and manufacturers to reduce prices for insurers and patients whenever possible. PBMs have […]

Drug Formularies Reduce Costs, Gain in Popularity

Workers’ compensation drug formularies are not a new idea, but only a few states currently have such mandated formularies in place, according to an article in Claims Journal. Only Washington, Texas, Ohio and Oklahoma have previously existing state-regulated drug formularies. California is the most recent state to make the change. In early October, Governor Jerry […]

HealthCare Seeking Solutions for Specialty Drugs Costs

The Centers for Medicare & Medicaid Services predicted that spending on prescription drugs would rise by 6.8 percent in 2014.   Their estimate was a bit off.   Instead, spending on prescription medications leaped by 13 percent to $374 billion, according to a recent paper from the IMS Institute for Healthcare Informatics. It was the […]

CEO of Kaiser Foundation Calls for Changes in Pharma

Kaiser exec calls for changes in pharma   Roughly 25 years ago, if you wanted a cell phone, a digital camera and a video camera, you would need to shell out almost $3,000. And for your money, you’d get big, clunky devices that provided primitive results.   These days, you can buy all of this […]

« Older posts